Sergey V. Kulemzin

737 total citations
33 papers, 470 citations indexed

About

Sergey V. Kulemzin is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Sergey V. Kulemzin has authored 33 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 19 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Sergey V. Kulemzin's work include CAR-T cell therapy research (19 papers), Immune Cell Function and Interaction (15 papers) and T-cell and B-cell Immunology (9 papers). Sergey V. Kulemzin is often cited by papers focused on CAR-T cell therapy research (19 papers), Immune Cell Function and Interaction (15 papers) and T-cell and B-cell Immunology (9 papers). Sergey V. Kulemzin collaborates with scholars based in Russia, United States and Germany. Sergey V. Kulemzin's co-authors include Ivan Akhrymuk, Elena I. Frolova, Andrey A. Gorchakov, Alexander V. Taranin, Г. В. Кочнева, Valeriya Kuznetsova, Olga Y. Volkova, Alexander M. Najakshin, Владимир П. Баклаушев and Andrey Zaritskey and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Virology and International Journal of Molecular Sciences.

In The Last Decade

Sergey V. Kulemzin

32 papers receiving 460 citations

Peers

Countries citing papers authored by Sergey V. Kulemzin

Since Specialization

Citations

This map shows the geographic impact of Sergey V. Kulemzin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergey V. Kulemzin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergey V. Kulemzin more than expected).

Fields of papers citing papers by Sergey V. Kulemzin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergey V. Kulemzin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergey V. Kulemzin. The network helps show where Sergey V. Kulemzin may publish in the future.

Co-authorship network of co-authors of Sergey V. Kulemzin

This figure shows the co-authorship network connecting the top 25 collaborators of Sergey V. Kulemzin. A scholar is included among the top collaborators of Sergey V. Kulemzin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergey V. Kulemzin. Sergey V. Kulemzin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Activity of Human NK Cells Towards 3D Heterotypic Cellular Tumor Model of Breast Cancer 2025 ·Cells ·(unknown), (unknown), Maria V. Bogachek, (unknown), (unknown), (unknown), Sergey V. Kulemzin, Vladimir A. Richter, Elena V. Kuligina, (unknown)	1
2	Serial Llama Immunization with Various SARS-CoV-2 RBD Variants Induces Broad Spectrum Virus-Neutralizing Nanobodies 2024 ·Vaccines ·(unknown), Alexander M. Najakshin, (unknown), Sergey V. Kulemzin, Ludmila V. Mechetina, (unknown), (unknown), Andrey A. Gorchakov, (unknown), (unknown), Olga Y. Volkova, (unknown), (unknown), А. Yu. Alekseev, Marina Gulyaeva, А. М. Шестопалов, Alexander V. Taranin	3
3	Hybrid Immunity from Gam-COVID-Vac Vaccination and Natural SARS-CoV-2 Infection Confers Broader Neutralizing Activity against Omicron Lineage VOCs Than Revaccination or Reinfection 2024 ·Vaccines ·Sergey V. Kulemzin, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Andrey A. Gorchakov, (unknown), (unknown), Olga Y. Volkova, (unknown), Alexander M. Najakshin, Alexander V. Taranin	1
4	Virus neutralizing antibodies in pseudovirus particle neutralization reaction as a bioanalytical part of a Salnavac® vaccine clinical trial 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Sergey V. Kulemzin, Dmitry Poteryaev, (unknown), (unknown), (unknown), (unknown)	1
5	Comparative Pre-Clinical Analysis of CD20-Specific CAR T Cells Encompassing 1F5-, Leu16-, and 2F2-Based Antigen-Recognition Moieties 2023 ·International Journal of Molecular Sciences ·(unknown), Sergey V. Kulemzin, Olga Y. Volkova, Alexander M. Najakshin, Alexander V. Taranin, Andrey A. Gorchakov	2
6	Memory B Cells Induced by Sputnik V Vaccination Produce SARS-CoV-2 Neutralizing Antibodies Upon Ex Vivo Restimulation 2022 ·Frontiers in Immunology ·(unknown), Sergey V. Kulemzin, (unknown), (unknown), Grigory A. Efimov, (unknown), (unknown), Andrey A. Gorchakov, Alexander V. Taranin, Alexander Filatov	11
7	Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies 2021 ·Journal of Personalized Medicine ·Sergey V. Kulemzin, (unknown), (unknown), Alexander V. Taranin, Andrey A. Gorchakov	2
8	VAV1‐overexpressing YT cells display improved cytotoxicity against malignant cells 2020 ·Biotechnology and Applied Biochemistry ·(unknown), Sergey V. Kulemzin, Gaukhar M. Yusubalieva, (unknown), (unknown), (unknown), (unknown), Vladimir A. Kalsin, Andrey A. Gorchakov, Владимир П. Баклаушев, Alexander V. Taranin	4
9	COVID-19. Etiology, pathogenesis, diagnosis and treatment 2020 ·SHILAP Revista de lepidopterología ·Владимир П. Баклаушев, Sergey V. Kulemzin, Andrey A. Gorchakov, (unknown), (unknown)	28
10	<i>shp-2</i> gene knockout upregulates CAR-driven cytotoxicity of YT NK cells 2020 ·Vavilov Journal of Genetics and Breeding ·(unknown), Sergey V. Kulemzin, (unknown), (unknown), (unknown), O. A. Koval, Andrey A. Gorchakov, Alexander V. Taranin	13
11	Design and analysis of stably integrated reporters for inducible transgene expression in human T cells and CAR NK-cell lines 2019 ·BMC Medical Genomics ·Sergey V. Kulemzin, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Alexander V. Taranin, Andrey A. Gorchakov	19
12	Prostate cancer surface targets for CAR T cell therapy or metastatic prostate cancer in the CAR T cell era: My kingdom for the target! 2019 ·Sergey V. Kulemzin, Andrey A. Gorchakov, Alexander V. Taranin	0
13	Challenges and Prospects of Chimeric Antigen Receptor T-cell Therapy for Metastatic Prostate Cancer 2019 ·European Urology ·Andrey A. Gorchakov, Sergey V. Kulemzin, Г. В. Кочнева, Alexander V. Taranin	45
14	A Simple Way to Increase Recovery of the Expressed VH and VL Genes in Single-Sorted Human B Cells 2019 ·BioTechniques ·(unknown), (unknown), Sergey V. Kulemzin, Andrey A. Gorchakov, Alexander V. Taranin	1
15	Analysis of in vitro activity of PSCA-specific CARs in the context of human NK cell line YT 2018 ·(unknown), Sergey V. Kulemzin, (unknown), (unknown), (unknown), Olga Y. Volkova, (unknown), O. A. Koval, Elena V. Kuligina, Alexander V. Taranin, Andrey A. Gorchakov	4
16	Diversity of Immunoglobulin Light Chain Genes in Non-Teleost Ray-Finned Fish Uncovers IgL Subdivision into Five Ancient Isotypes 2018 ·Frontiers in Immunology ·(unknown), (unknown), Alexander M. Najakshin, Ludmila V. Mechetina, (unknown), Alex Makunin, Sergey V. Kulemzin, (unknown), Matthias Stöck, Sven Wuertz, Jörn Geßner, Wesley C. Warren, Manfred Schartl, Vladimir A. Trifonov, Alexander V. Taranin	5
17	CAR T-cell therapy: Balance of efficacy and safety 2017 ·Molecular Biology ·Sergey V. Kulemzin, Valeriya Kuznetsova, Maksim Mamonkin, Alexander V. Taranin, Andrey A. Gorchakov	4
18	Development and Characterization of Domain-Specific Monoclonal Antibodies Produced Against Human SLAMF9 2014 ·Monoclonal Antibodies in Immunodiagnosis and Immunotherapy ·Olga Y. Volkova, (unknown), Ludmila V. Mechetina, (unknown), (unknown), Sergey V. Kulemzin, (unknown), Alexander M. Najakshin, Alexander V. Taranin	6
19	Characterization of human FCRLA isoforms 2013 ·Immunology Letters ·Sergey V. Kulemzin, (unknown), Olga Y. Volkova, (unknown), Alexander V. Taranin, Alexander M. Najakshin, Ludmila V. Mechetina	5
20	FCRLA is a resident endoplasmic reticulum protein that associates with intracellular Igs, IgM, IgG and IgA 2010 ·International Immunology ·Teresa Santiago, Sergey V. Kulemzin, (unknown), (unknown), Olga Y. Volkova, (unknown), Meina Zhao, Randall S. Davis, Alexander V. Taranin, Alexander M. Najakshin, Linda M. Hendershot, Peter D. Burrows	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact